Your browser doesn't support javascript.
Clinical Characteristics of Patients With Re-admitted of Novel Coronavirus 2019 (nCOVID-19) in Wenzhou, China.
Ye, Xinchun; Yuan, Yuping; Huang, Risheng; Cheng, Aiqiong; Yu, Zhijie; Huang, Ziyang; Chen, Rongrong; Jiang, Xiangao; Zheng, Yuanliang; Shi, Jichan.
  • Ye X; Department of Gastroenterology, Wenzhou Central Hospital, Wenzhou, China.
  • Yuan Y; Department of Infectious Disease, Wenzhou Central Hospital, Wenzhou, China.
  • Huang R; Department of Thoracic Surgery, Wenzhou Central Hospital, Wenzhou, China.
  • Cheng A; Department of Infectious Disease, Wenzhou Central Hospital, Wenzhou, China.
  • Yu Z; Department of Hematology, Wenzhou Key Laboratory of Hematology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
  • Huang Z; Department of Hematology, Wenzhou Key Laboratory of Hematology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
  • Chen R; Department of Hematology, Wenzhou Key Laboratory of Hematology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
  • Jiang X; Department of Infectious Disease, Wenzhou Central Hospital, Wenzhou, China.
  • Zheng Y; Department of Thoracic Surgery, Wenzhou Central Hospital, Wenzhou, China.
  • Shi J; Department of Infectious Disease, Wenzhou Central Hospital, Wenzhou, China.
Front Public Health ; 9: 649178, 2021.
Article in English | MEDLINE | ID: covidwho-1247944
ABSTRACT

Background:

During the COVID-19 pandemic, many patients admitted to hospital for treatment have recovered and been discharged; however, in some instances, these same patients are re-admitted due to a second fever or a positive COVID-19 PCR test result. To ascertain whether it is necessary to treat these patients in hospitals, especially in asymptomatic cases, we summarize and analyze the clinical and treatment characteristics of patients re-admitted to hospital with a second COVID-19 infection.

Methods:

Of the 141 COVID-19 cases admitted to the Wenzhou Central Hospital between January 17, 2020, to March 5, 2020, which were followed until March 30, 2020, 12 patients were re-admitted with a second COVID-19 infection. Data was collected and analyzed from their clinical records, lab indexes, commuted tomography (CT), and treatment strategies.

Results:

Most of the 141 patients had positive outcomes from treatment, with only 12 (8.5%) being re-admitted. In this sub-group one (8.3%) had a fever, a high white blood cell count (WBC), and progressive CT changes; and one (8.3%) had increased transaminase. The PCR tests of these two patients returned negative results. Another 10 patients were admitted due to a positive PCR test result, seven of which were clinically asymptomatic. Compared to the CT imaging following their initial discharge, the CT imaging of all patients was significantly improved, and none required additional oxygen or mechanical ventilation during their second course of treatment.

Conclusions:

The prognoses of the re-admitted patients were good with no serious cases. We conclude that home treatment with concentrated medical observation is a safe and feasible course of treatment if the patient returns a positive PCR test result but does not display serious clinical symptoms. During medical observation, patients with underlying conditions should remain a primary focus, but most do not need to be re-admitted to the hospital.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Patient Readmission / COVID-19 Type of study: Observational study / Prognostic study Limits: Humans Country/Region as subject: Asia Language: English Journal: Front Public Health Year: 2021 Document Type: Article Affiliation country: Fpubh.2021.649178

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Patient Readmission / COVID-19 Type of study: Observational study / Prognostic study Limits: Humans Country/Region as subject: Asia Language: English Journal: Front Public Health Year: 2021 Document Type: Article Affiliation country: Fpubh.2021.649178